| Product Information |
|
| Registration Number |
DRP-4116-05
|
| Generic Name |
Irinotecan hydrochloride
|
| Brand Name |
Irixtar
|
| Dosage Strength |
20 mg/mL
|
| Dosage Form |
Solution for Injection (IV)
|
| Classification |
Prescription Drug (Rx)
|
| Pharmacologic Category |
Antineoplastic (Cell cycle-specific agent)
|
| Packaging |
40 mg/2 mL USP Type I Amber Glass Tubular Vial per box and 100 mg/5 mL USP Type I Amber Glass Tubular Vial per box /
|
| Manufacturer |
Venus Remedies, Limited
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
Bliss Pharma Distribution and Consultancy Corp.
|
| Distributor |
Pharmastar Int'l Trading Corp.
|
| Application Type |
CLIDP Conversion
|
| Issuance Date |
26 February 2024
|
| Expiry Date |
03 November 2027
|